Celyad Oncology S.A.

CYAD.BR · BRU
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-€4-€3-€3-€5
Dep. & Amort.€0€0€0€0
Deferred Tax€0€0€0€0
Stock-Based Comp.€0-€0€0€0
Change in WC€0-€0€0€2
Other Non-Cash€4€0-€0-€5
Operating Cash Flow€0-€3-€3-€7
Investing Activities
PP&E Inv.€0-€0-€0-€1
Net Acquisitions€0€0€0€0
Inv. Purchases€0€0€0€0
Inv. Sales/Matur.€0€0€0€0
Other Inv. Act.€0€0€0-€0
Investing Cash Flow€0€0-€0-€1
Financing Activities
Debt Repay.€0€0-€0€0
Stock Issued€0€0€0€9
Stock Repurch.€0€0€0€0
Dividends Paid€0€0€0€0
Other Fin. Act.€0€1€2-€0
Financing Cash Flow€0€1€2€9
Forex Effect€0-€0€0€0
Net Chg. in Cash€0-€2-€1€2
Supplemental Information
Beg. Cash€0€6€7€5
End Cash€0€4€6€7
Free Cash Flow€0-€3-€3-€7
Celyad Oncology S.A. (CYAD.BR) Financial Statements & Key Stats | AlphaPilot